Chart showing global vaccine trial trends

Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible

1 min read

The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation have created uncertainty and slowed progress. For many scientists and innovators focusing on vaccines, this has been a difficult time.

At Polygon Health Analytics, we believe that access to reliable data should never be a barrier to scientific progress. To address these challenges, we’re proud to introduce the Vaccine Trial Atlas, a free, interactive dashboard designed to make vaccine-related clinical trial data easier to find, understand, and use.

Why Vaccine Trial Atlas?

ClinicalTrials.gov, launched in 2000, remains the cornerstone for clinical trial transparency. However, its complexity often limits usability for researchers, healthcare professionals, policymakers, and the public. Common challenges include:

  • A non-intuitive interface and overwhelming search experience
  • Dense, technical language in trial descriptions
  • Inconsistent formatting and terminology across studies
  • Limited filtering options for targeted analysis

These barriers make it difficult, even for experts, to extract actionable insights.

Our Solution

The Vaccine Trial Atlas simplifies this process by providing a centralized, user-friendly platform focused on interventional vaccine studies. Built on data from the Aggregate Analysis of ClinicalTrials.gov (AACT), the dashboard offers:

  • Comprehensive Data Access – Aggregated vaccine trial data with advanced filtering
  • Standardized Terminology – Consistent mapping of conditions and interventions
  • Customizable Search & Filters – Explore by disease, phase, geography, sponsor type, and more
  • Interactive Visualizations – Track trends across time, regions, and trial phases
  • Export & Share – Download datasets in CSV for deeper analysis and collaboration

👉 [Explore the Vaccine Trial Atlas]

Join Us in Driving Transparency

The Vaccine Trial Atlas is just the beginning. We invite researchers, organizations, and policymakers to collaborate with us as we expand this platform to cover broader therapeutic areas and more advanced features.

For feedback, inquiries, or partnership opportunities, contact us at info@polygonhealthanalytics.com.

Other Posts You Might Like

Launchpad
Polygon Health Analytics Celebrates Graduation of 2025 Launchpad Cohort
Sep 03, 2025
[Philadelphia, September 2, 2025] – Polygon Health Analytics proudly announces the successful graduation of its 2025 Launchpad Program cohort—the second since the program’s inception—marking...
Read more
Patient_Reported_With_Doctor
Patient-Reported Outcomes: Bringing the Patient’s Voice into Clinical Development and Outcomes Research
Aug 14, 2025
When it comes to healthcare, numbers and lab results only tell part of the story. What about how patients feel? How treatments impact their daily lives?...
Read more
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Jul 28, 2025
In a world where AI headlines are dominated by billion-dollar fundraises, massive model sizes, and compute power arms races, Edwin Chen offers a refreshing counter-narrative. As...
Read more
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Jul 15, 2025
If you're a scientist transitioning into the biotechnology sector or an entrepreneur developing a novel therapy for an unmet medical need, one term will...
Read more
Literature Reviews
Systematic Literature Reviews and AI: A Gold Standard Meets Innovation
Jun 01, 2025
Discover how Systematic Literature Reviews (SLRs) provide a gold-standard method for evidence synthesis in biomedicine—and how AI is transforming the process. Learn the key steps, differences from other review types, and the future potential of automation in research....
Read more
Perfect timing
No Perfect Timing: Embracing Uncertainty in Business and Life
Apr 16, 2025
"Is now the right time?" It’s a question I hear often—from aspiring entrepreneurs, working parents, and close friends. Whether it’s starting...
Read more
Calling for Lupus Patients and Caregivers to Shape the Future of Lupus Care
Calling for Lupus Patients and Caregivers to Shape the Future of Lupus Care
Mar 11, 2025
Sponsored by the National Institute of Minority Health and Health Disparities (NIMHD), Polygon Health Analytics is iSMILE (Individualized Social Risk Management in Systemic Lupus Erythematosus Care)...
Read more
AI_Life_Science
Is Life Science Ready for AI?
Jan 01, 2025
A few days ago, Dr. Geoffrey Hinton, often referred to as the “Godfather of AI,” made a chilling statement: “There is a 10-20 percent probability that...
Read more
Lupus
Polygon Health Analytics Receives Competitive SBIR Grant from NIMHD to Address Health Disparities in Lupus Care
Nov 19, 2024
Philadelphia, PA — Nov 19, 2024 — Polygon Health Analytics LLC is proud to announce its award of a $295,924 Small Business Innovation Research (SBIR) Phase I...
Read more
Polygon Health Analytics Launches First Cohort of Launchpad Program
Polygon Health Analytics Launches First Cohort of Launchpad Program
Nov 10, 2024
Polygon Health Analytics is excited to announce the successful graduation of the first cohort of its Launchpad Program, a 3-to-6-month train-to-hire initiative designed to prepare emerging...
Read more
View all